{"entity":{"type":"insider","cik":"0001486373","url":"/insider/0001486373","json_url":"/insider/0001486373.json","name":"Cole Douglas G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":14,"first":"2010-12-03","last":"2011-05-16","span_basis":"filed_date"},"name_variants":[{"name":"Cole Douglas G.","source":"filing","n_filings":14,"first_seen":"2010-12-03","last_seen":"2011-05-16"}],"transactions":[{"id":9178616,"accession":"0001181431-11-030133","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-11-030133","line_url":"/filing/0001181431-11-030133","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52492.0,"shares_display":"52,492","price_per_share":17.977294300083823,"price_display":"17.98","price_state":"stated","total_value":943664.1324,"total_display":"943,664.13","total_whole":"943,664","shares_owned_after":395565.0,"shares_owned_after_display":"395,565","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-16","scope":"insider","n_lines":2},{"id":9178614,"accession":"0001181431-11-030133","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-11-030133","line_url":"/filing/0001181431-11-030133","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81389.0,"shares_display":"81,389","price_per_share":17.75179430021256,"price_display":"17.75","price_state":"stated","total_value":1444800.7863,"total_display":"1,444,800.79","total_whole":"1,444,801","shares_owned_after":445065.0,"shares_owned_after_display":"445,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-13","filed_date":"2011-05-16","scope":"insider","n_lines":2},{"id":9178612,"accession":"0001181431-11-030133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-030133","line_url":"/filing/0001181431-11-030133","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16119.0,"shares_display":"16,119","price_per_share":17.3033,"price_display":"17.30","price_state":"stated","total_value":278911.8927,"total_display":"278,911.89","total_whole":"278,912","shares_owned_after":521815.0,"shares_owned_after_display":"521,815","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-12","filed_date":"2011-05-16","scope":"insider","n_lines":2},{"id":9101227,"accession":"0001181431-11-000234","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-11-000234","line_url":"/filing/0001181431-11-000234","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6400.0,"shares_display":"6,400","price_per_share":14.5304,"price_display":"14.53","price_state":"stated","total_value":92994.56,"total_display":"92,994.56","total_whole":"92,995","shares_owned_after":600248.0,"shares_owned_after_display":"600,248","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-01-03","filed_date":"2011-01-03","scope":"insider","n_lines":2},{"id":9101225,"accession":"0001181431-11-000234","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-11-000234","line_url":"/filing/0001181431-11-000234","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19493.0,"shares_display":"19,493","price_per_share":14.5564,"price_display":"14.56","price_state":"stated","total_value":283747.9052,"total_display":"283,747.91","total_whole":"283,748","shares_owned_after":606284.0,"shares_owned_after_display":"606,284","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-31","filed_date":"2011-01-03","scope":"insider","n_lines":2},{"id":9101223,"accession":"0001181431-11-000234","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-000234","line_url":"/filing/0001181431-11-000234","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":14.6212,"price_display":"14.62","price_state":"stated","total_value":95037.8,"total_display":"95,037.80","total_whole":"95,038","shares_owned_after":624668.0,"shares_owned_after_display":"624,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-30","filed_date":"2011-01-03","scope":"insider","n_lines":2},{"id":7202138,"accession":"0001181431-10-064094","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-064094","line_url":"/filing/0001181431-10-064094","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14112.0,"shares_display":"14,112","price_per_share":14.4967,"price_display":"14.50","price_state":"stated","total_value":204577.4304,"total_display":"204,577.43","total_whole":"204,577","shares_owned_after":630798.0,"shares_owned_after_display":"630,798","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-29","filed_date":"2010-12-29","scope":"insider","n_lines":2},{"id":7202135,"accession":"0001181431-10-064094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-064094","line_url":"/filing/0001181431-10-064094","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9735.0,"shares_display":"9,735","price_per_share":14.623,"price_display":"14.62","price_state":"stated","total_value":142354.905,"total_display":"142,354.90","total_whole":"142,355","shares_owned_after":644106.0,"shares_owned_after_display":"644,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-28","filed_date":"2010-12-29","scope":"insider","n_lines":2},{"id":7768797,"accession":"0001181431-10-063685","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-063685","line_url":"/filing/0001181431-10-063685","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9196.0,"shares_display":"9,196","price_per_share":14.5316,"price_display":"14.53","price_state":"stated","total_value":133632.5936,"total_display":"133,632.59","total_whole":"133,633","shares_owned_after":653286.0,"shares_owned_after_display":"653,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-27","filed_date":"2010-12-27","scope":"insider","n_lines":2},{"id":7768793,"accession":"0001181431-10-063685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-063685","line_url":"/filing/0001181431-10-063685","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4765.0,"shares_display":"4,765","price_per_share":14.6014,"price_display":"14.60","price_state":"stated","total_value":69575.671,"total_display":"69,575.67","total_whole":"69,576","shares_owned_after":661958.0,"shares_owned_after_display":"661,958","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-23","filed_date":"2010-12-27","scope":"insider","n_lines":2},{"id":7570241,"accession":"0001181431-10-063331","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-063331","line_url":"/filing/0001181431-10-063331","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":14.6813,"price_display":"14.68","price_state":"stated","total_value":256922.75,"total_display":"256,922.75","total_whole":"256,923","shares_owned_after":666451.0,"shares_owned_after_display":"666,451","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-22","filed_date":"2010-12-22","scope":"insider","n_lines":2},{"id":7570238,"accession":"0001181431-10-063331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-063331","line_url":"/filing/0001181431-10-063331","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14800.0,"shares_display":"14,800","price_per_share":14.2881,"price_display":"14.29","price_state":"stated","total_value":211463.88,"total_display":"211,463.88","total_whole":"211,464","shares_owned_after":682954.0,"shares_owned_after_display":"682,954","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-21","filed_date":"2010-12-22","scope":"insider","n_lines":2},{"id":7239000,"accession":"0001181431-10-063072","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-063072","line_url":"/filing/0001181431-10-063072","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20500.0,"shares_display":"20,500","price_per_share":14.1117,"price_display":"14.11","price_state":"stated","total_value":289289.85,"total_display":"289,289.85","total_whole":"289,290","shares_owned_after":696910.0,"shares_owned_after_display":"696,910","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-20","filed_date":"2010-12-21","scope":"insider","n_lines":2},{"id":7238994,"accession":"0001181431-10-063072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-063072","line_url":"/filing/0001181431-10-063072","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11549.0,"shares_display":"11,549","price_per_share":14.0675,"price_display":"14.07","price_state":"stated","total_value":162465.5575,"total_display":"162,465.56","total_whole":"162,466","shares_owned_after":716242.0,"shares_owned_after_display":"716,242","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-17","filed_date":"2010-12-21","scope":"insider","n_lines":2},{"id":7342013,"accession":"0001181431-10-062499","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-062499","line_url":"/filing/0001181431-10-062499","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11507.0,"shares_display":"11,507","price_per_share":14.2111,"price_display":"14.21","price_state":"stated","total_value":163527.1277,"total_display":"163,527.13","total_whole":"163,527","shares_owned_after":727133.0,"shares_owned_after_display":"727,133","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-16","filed_date":"2010-12-17","scope":"insider","n_lines":2},{"id":7342009,"accession":"0001181431-10-062499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-062499","line_url":"/filing/0001181431-10-062499","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":14.1389,"price_display":"14.14","price_state":"stated","total_value":104627.86,"total_display":"104,627.86","total_whole":"104,628","shares_owned_after":737984.0,"shares_owned_after_display":"737,984","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-15","filed_date":"2010-12-17","scope":"insider","n_lines":2},{"id":7238748,"accession":"0001181431-10-062047","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-062047","line_url":"/filing/0001181431-10-062047","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10900.0,"shares_display":"10,900","price_per_share":14.0594,"price_display":"14.06","price_state":"stated","total_value":153247.46,"total_display":"153,247.46","total_whole":"153,247","shares_owned_after":744962.0,"shares_owned_after_display":"744,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-14","filed_date":"2010-12-15","scope":"insider","n_lines":2},{"id":7238744,"accession":"0001181431-10-062047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-062047","line_url":"/filing/0001181431-10-062047","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10600.0,"shares_display":"10,600","price_per_share":14.5395,"price_display":"14.54","price_state":"stated","total_value":154118.7,"total_display":"154,118.70","total_whole":"154,119","shares_owned_after":755240.0,"shares_owned_after_display":"755,240","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-13","filed_date":"2010-12-15","scope":"insider","n_lines":2},{"id":7508478,"accession":"0001181431-10-061187","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-061187","line_url":"/filing/0001181431-10-061187","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9100.0,"shares_display":"9,100","price_per_share":14.4724,"price_display":"14.47","price_state":"stated","total_value":131698.84,"total_display":"131,698.84","total_whole":"131,699","shares_owned_after":765236.0,"shares_owned_after_display":"765,236","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-10","filed_date":"2010-12-13","scope":"insider","n_lines":2},{"id":7508474,"accession":"0001181431-10-061187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-061187","line_url":"/filing/0001181431-10-061187","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":14.3941,"price_display":"14.39","price_state":"stated","total_value":120910.44,"total_display":"120,910.44","total_whole":"120,910","shares_owned_after":773817.0,"shares_owned_after_display":"773,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-09","filed_date":"2010-12-13","scope":"insider","n_lines":2},{"id":9251978,"accession":"0001181431-11-019470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-019470","line_url":"/filing/0001181431-11-019470#line-1","is_derivative":false,"issuer_cik":"0001486373","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001486373","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25838.0,"shares_display":"25,838","price_per_share":14.9304,"price_display":"14.93","price_state":"stated","total_value":385771.6752,"total_display":"385,771.68","total_whole":"385,772","shares_owned_after":718505.0,"shares_owned_after_display":"718,505","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-08","filed_date":"2011-03-22","scope":"insider"},{"id":9251963,"accession":"0001181431-11-016805","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-016805","line_url":"/filing/0001181431-11-016805","is_derivative":false,"issuer_cik":"0001486373","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001486373","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27400.0,"shares_display":"27,400","price_per_share":14.9304,"price_display":"14.93","price_state":"stated","total_value":409092.96,"total_display":"409,092.96","total_whole":"409,093","shares_owned_after":43426.0,"shares_owned_after_display":"43,426","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-08","filed_date":"2011-03-09","scope":"insider","n_lines":2},{"id":7688829,"accession":"0001181431-10-060553","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-060553","line_url":"/filing/0001181431-10-060553","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27400.0,"shares_display":"27,400","price_per_share":14.9304,"price_display":"14.93","price_state":"stated","total_value":409092.96,"total_display":"409,092.96","total_whole":"409,093","shares_owned_after":781738.0,"shares_owned_after_display":"781,738","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-08","filed_date":"2010-12-09","scope":"insider","n_lines":2},{"id":9251962,"accession":"0001181431-11-016805","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-016805","line_url":"/filing/0001181431-11-016805","is_derivative":false,"issuer_cik":"0001486373","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001486373","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6294.0,"shares_display":"6,294","price_per_share":14.9319,"price_display":"14.93","price_state":"stated","total_value":93981.3786,"total_display":"93,981.38","total_whole":"93,981","shares_owned_after":744343.0,"shares_owned_after_display":"744,343","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-07","filed_date":"2011-03-09","scope":"insider","n_lines":2},{"id":7688823,"accession":"0001181431-10-060553","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-060553","line_url":"/filing/0001181431-10-060553","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6294.0,"shares_display":"6,294","price_per_share":14.9319,"price_display":"14.93","price_state":"stated","total_value":93981.3786,"total_display":"93,981.38","total_whole":"93,981","shares_owned_after":807576.0,"shares_owned_after_display":"807,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-07","filed_date":"2010-12-09","scope":"insider","n_lines":2},{"id":7712974,"accession":"0001181431-10-060063","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-060063","line_url":"/filing/0001181431-10-060063#line-4","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486373","owner_name":"Cole Douglas G.","owner_display_name":"Cole Douglas G.","owner_url":"/insider/0001486373","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13674.0,"shares_display":"13,674","price_per_share":14.9228,"price_display":"14.92","price_state":"stated","total_value":204054.3672,"total_display":"204,054.37","total_whole":"204,054","shares_owned_after":799837.0,"shares_owned_after_display":"799,837","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-06","filed_date":"2010-12-07","scope":"insider"}],"collapsed":true,"next_cursor":"2010-12-06|7712974","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":57,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS INC","url":"/issuer/0001325879","role":"Director","n_filings":14,"first_seen":"2010-12-03","last_seen":"2011-05-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001486373","retrieved_at":"2026-08-24T14:57:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}